Obstructive sleep apnea and heart failure

Virend Somers, Andrew D. Calvin, Felipe N. Albuquerque, Taro Adachi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Opinion statement: Obstructive sleep apnea (OSA) exerts several effects that may be particularly deleterious in patients with heart failure (HF). OSA should be considered especially in HF patients who are obese or have the metabolic syndrome, systemic hypertension, or pulmonary hypertension. HF patients in whom OSA is suspected should undergo a full evaluation by a sleep specialist, including a polysomnogram, to diagnose OSA and differentiate this disease from central sleep apnea. Those found to have OSA should then receive continuous positive airway pressure and/or other interventions, and standard disease management strategies should be used to maximize compliance. Those who cannot tolerate continuous positive airway pressure may be candidates for mandibular advancement devices or surgical therapies including tracheostomy. Standard HF medications should be used to treat HF, and optimization of fluid balance may help minimize OSA severity. However, it is still unknown whether treatment of OSA in HF patients will reduce hospitalizations or mortality.

Original languageEnglish (US)
Pages (from-to)447-454
Number of pages8
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume11
Issue number6
DOIs
StatePublished - 2009

Fingerprint

Obstructive Sleep Apnea
Heart Failure
Continuous Positive Airway Pressure
Mandibular Advancement
Central Sleep Apnea
Water-Electrolyte Balance
Tracheostomy
Disease Management
Pulmonary Hypertension
Compliance
Sleep
Hospitalization
Hypertension
Equipment and Supplies
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Obstructive sleep apnea and heart failure. / Somers, Virend; Calvin, Andrew D.; Albuquerque, Felipe N.; Adachi, Taro.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 11, No. 6, 2009, p. 447-454.

Research output: Contribution to journalArticle

Somers, Virend ; Calvin, Andrew D. ; Albuquerque, Felipe N. ; Adachi, Taro. / Obstructive sleep apnea and heart failure. In: Current Treatment Options in Cardiovascular Medicine. 2009 ; Vol. 11, No. 6. pp. 447-454.
@article{15b50b38df284e8fae7953a5e89a37ba,
title = "Obstructive sleep apnea and heart failure",
abstract = "Opinion statement: Obstructive sleep apnea (OSA) exerts several effects that may be particularly deleterious in patients with heart failure (HF). OSA should be considered especially in HF patients who are obese or have the metabolic syndrome, systemic hypertension, or pulmonary hypertension. HF patients in whom OSA is suspected should undergo a full evaluation by a sleep specialist, including a polysomnogram, to diagnose OSA and differentiate this disease from central sleep apnea. Those found to have OSA should then receive continuous positive airway pressure and/or other interventions, and standard disease management strategies should be used to maximize compliance. Those who cannot tolerate continuous positive airway pressure may be candidates for mandibular advancement devices or surgical therapies including tracheostomy. Standard HF medications should be used to treat HF, and optimization of fluid balance may help minimize OSA severity. However, it is still unknown whether treatment of OSA in HF patients will reduce hospitalizations or mortality.",
author = "Virend Somers and Calvin, {Andrew D.} and Albuquerque, {Felipe N.} and Taro Adachi",
year = "2009",
doi = "10.1007/s11936-009-0047-z",
language = "English (US)",
volume = "11",
pages = "447--454",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "6",

}

TY - JOUR

T1 - Obstructive sleep apnea and heart failure

AU - Somers, Virend

AU - Calvin, Andrew D.

AU - Albuquerque, Felipe N.

AU - Adachi, Taro

PY - 2009

Y1 - 2009

N2 - Opinion statement: Obstructive sleep apnea (OSA) exerts several effects that may be particularly deleterious in patients with heart failure (HF). OSA should be considered especially in HF patients who are obese or have the metabolic syndrome, systemic hypertension, or pulmonary hypertension. HF patients in whom OSA is suspected should undergo a full evaluation by a sleep specialist, including a polysomnogram, to diagnose OSA and differentiate this disease from central sleep apnea. Those found to have OSA should then receive continuous positive airway pressure and/or other interventions, and standard disease management strategies should be used to maximize compliance. Those who cannot tolerate continuous positive airway pressure may be candidates for mandibular advancement devices or surgical therapies including tracheostomy. Standard HF medications should be used to treat HF, and optimization of fluid balance may help minimize OSA severity. However, it is still unknown whether treatment of OSA in HF patients will reduce hospitalizations or mortality.

AB - Opinion statement: Obstructive sleep apnea (OSA) exerts several effects that may be particularly deleterious in patients with heart failure (HF). OSA should be considered especially in HF patients who are obese or have the metabolic syndrome, systemic hypertension, or pulmonary hypertension. HF patients in whom OSA is suspected should undergo a full evaluation by a sleep specialist, including a polysomnogram, to diagnose OSA and differentiate this disease from central sleep apnea. Those found to have OSA should then receive continuous positive airway pressure and/or other interventions, and standard disease management strategies should be used to maximize compliance. Those who cannot tolerate continuous positive airway pressure may be candidates for mandibular advancement devices or surgical therapies including tracheostomy. Standard HF medications should be used to treat HF, and optimization of fluid balance may help minimize OSA severity. However, it is still unknown whether treatment of OSA in HF patients will reduce hospitalizations or mortality.

UR - http://www.scopus.com/inward/record.url?scp=70449499080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449499080&partnerID=8YFLogxK

U2 - 10.1007/s11936-009-0047-z

DO - 10.1007/s11936-009-0047-z

M3 - Article

VL - 11

SP - 447

EP - 454

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 6

ER -